Landsberg and coworkers demonstrated that immunotherapy-resistant melanoma cells xenografted in nude mice models undergo a dedifferentiation process characterized by the concurrent gain of the stemness marker nerve growth factor receptor (NGFR) and loss of TAAs [239]. This evidence concerns the gene NGFR and melanoma.